ResearcherEngeneic Pty LimitedActive in the last 2 years

Himanshu Brahmbhatt

Provisional: name at one institution (moderate confidence)As of 13 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 0
Pancreatic cancer trials: 1
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 trial

Trials 1

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer Study director NCT07049055 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Jennifer MacDiarmid · 1 shared trial, 2026
- Trial A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer NCT07049055 ↗
Linda Y.Wu · 1 shared trial, 2026
- Trial A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer NCT07049055 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.